|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,056 GBX | -0.41% |
|
-2.43% | +13.74% |
| 07-05 | AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer | MT |
| 07-05 | AstraZeneca: cancer treatment approved by the EU | CF |
(Reuters) - AstraZeneca on Thursday topped analysts' expectations for third-quarter profit and sales, and raised its full-year adjusted earnings forecast.
(Reporting by Natalie Grover in London. Editing by Jane Merriman)
| 1st Jan change | Capi. | |
|---|---|---|
| +13.74% | 239B | |
| +56.89% | 823B | |
| +39.52% | 627B | |
| -6.55% | 353B | |
| +7.92% | 295B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 167B | |
| -2.57% | 159B | |
| +1.31% | 123B |
ASTRAZENECA PLC 
